We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+2.62%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$170M
AUM Growth
+$1.92M
(+1.1%)
Cap. Flow
+$1.49M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
41.96%
Holding
117
New
6
Increased
39
Reduced
48
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$765K |
| 2 |
Advanced Micro Devices
AMD
|
+$615K |
| 3 |
GE Vernova
GEV
|
+$615K |
| 4 |
Walt Disney
DIS
|
+$589K |
| 5 |
AbbVie
ABBV
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$506K |
| 2 |
TSMC
TSM
|
+$339K |
| 3 |
Albemarle
ALB
|
+$337K |
| 4 |
JPMorgan Chase
JPM
|
+$310K |
| 5 |
NVO
Novo Nordisk
NVO
|
+$298K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.64% |
| 2 | Consumer Staples | 11.55% |
| 3 | Healthcare | 11.29% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Financials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Salesforce
CRM
$151B
| $219K | 0.13% |
+655
| New | +$209K |
|
102
iShares TIPS Bond ETF
TIP
$14.5B
| $216K | 0.13% |
2,030
| – | – |
|
103
International Flavors & Fragrances
IFF
$20.2B
| $212K | 0.12% |
2,511
-25
| -1% | -$2.35K |
|
104
Illinois Tool Works
ITW
$82.6B
| $212K | 0.12% |
837
| – | – |
|
105
Kimberly-Clark
KMB
$36.3B
| $212K | 0.12% |
+1,615
| New | +$220K |
|
106
Travelers Companies
TRV
$78.1B
| $211K | 0.12% |
876
| – | – |
|
107
Morgan Stanley
MS
$331B
| $205K | 0.12% |
+1,632
| New | +$201K |
|
108
AES
AES
$10.5B
| $199K | 0.12% |
15,472
-292
| -2% | -$4.36K |
|
109
Wolfspeed
WOLF
$1.23B
| $113K | 0.07% |
16,917
-575
| -3% | -$5.86K |
|
|
TE
110
T1 Energy
TE
$1.16B
| $36.1K | 0.02% |
14,000
-5,550
| -28% | -$9.31K |
|
|
111
Albemarle
ALB
$13.9B
| – | – |
-3,562
| Closed | -$337K |
|
112
Boeing
BA
$171B
| – | – |
-1,686
| Closed | -$256K |
|
113
CRISPR Therapeutics
CRSP
$4.73B
| – | – |
-5,720
| Closed | -$269K |
|
114
Fortrea Holdings
FTRE
$1.82B
| – | – |
-10,502
| Closed | -$210K |
|
115
GXO Logistics
GXO
$5.77B
| – | – |
-4,125
| Closed | -$215K |
|
116
Iovance Biotherapeutics
IOVA
$1.82B
| – | – |
-14,575
| Closed | -$137K |
|
117
Merchants Bancorp
MBIN
$2.53B
| – | – |
-4,627
| Closed | -$208K |
|
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q4 2024 Portfolio in Review
As of Q4 2024, Fairfield, Bush & Co held 117 positions worth $170M, up 1.1% from $168M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Fairfield, Bush & Co's Q4 2024 filing shows 6 new, 39 increased, 48 reduced and 7 closed positions. Its largest new stake was GE Vernova: 1,968 shares worth $647K. The largest sale was Thermo Fisher Scientific, an estimated $506K.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Healthcare.
- Fairfield, Bush & Co's largest Q4 2024 buy was GE Vernova: 1,968 shares worth $647K.
- Fairfield, Bush & Co added most to GE Aerospace in Q4 2024, an estimated $765K increase.
- Fairfield, Bush & Co's biggest Q4 2024 reduction was Thermo Fisher Scientific, cutting an estimated $506K.
- Fairfield, Bush & Co fully exited Albemarle in Q4 2024, selling an estimated $337K.
- Fairfield, Bush & Co's ten largest holdings make up 42% of its $170M portfolio in Q4 2024.
- Fairfield, Bush & Co opened 6 new positions and closed 7 in Q4 2024.
- Fairfield, Bush & Co's portfolio value rose 1.1% quarter-over-quarter to $170M.
Based on Fairfield, Bush & Co's 13F filing for Q4 2024, filed 13 Feb 2025.